Daniel Katzman work email
- Valid
- Valid
Daniel Katzman personal email
Daniel Katzman phone numbers
Daniel Katzman is a Biotech Executive and Entrepreneur at Asclepii. He possess expertise in start ups, medical devices, strategy, business strategy, biotechnology and 24 more skills. He is proficient in Hebrew.
-
Ceo And FounderUnleash Immuno Oncolytics Jul 2015 - PresentAt Unleash, I lead our mission to revolutionize cancer treatment through our pioneering oncolytic virus platform. Steering the strategic direction and innovation, I oversee our efforts to develop and commercialize next-generation therapies that target the tumor microenvironment for more effective and less invasive cancer care. Under my leadership, we have successfully advanced our lead product, UIO-524, into clinical testing for bladder cancer, secured significant fundraising, and built a robust intellectual property portfolio. Our focus on developing treatments that address unmet needs in cancer care drives our team towards delivering transformative outcomes for patients worldwide.
-
Chairman And Co-FounderAsclepii Oct 2022 - PresentActively engaged in the foundational stages of the company, providing strategic guidance on business development and fundraising initiatives. My role has been instrumental in shaping the company’s vision and ensuring the alignment of our growth strategies with industry standards and investor expectations. -
CeoPrecision Virologics Aug 2016 - May 2020Precision Virologics’ biologically targeted adenovirus vaccines provide a new approach to the expanding threat of emerging infectious diseases. Emerging infectious diseases represent a grave threat to global health, agriculture and the economy. Zika infection continues to be a national healthcare priority. The markets for Zika vaccines is estimated at well over one billion dollars. The NIH and pharma companies rushed to the clinic with sub-optimal vaccines for Zika. Particularly they share a potentially fatal flaw related to the cross-reactivity with Dengue, which may limit their potential to get approved. The cross-reactivity of existing Zika vaccines may leave vaccinated individuals subject to a significantly more severe reaction to Dengue. Precision’s technology embodies critical advantages over competitors both in terms of potency and lack of cross-reactivity with Dengue.
-
Venture PartnerAxia Ventures Sep 2013 - Dec 2016Rio De Janeiro, Br -
PresidentNeurohealing Pharmaceuticals Inc. Jul 2003 - Nov 2011
-
Vp Business DevelopmentOridion Medical 1996 - 2003
Daniel Katzman Skills
Daniel Katzman Education Details
-
Universidad Nacional De La PlataBiochemistry -
Colegio Nacional De La PlataBachiller
Frequently Asked Questions about Daniel Katzman
What company does Daniel Katzman work for?
Daniel Katzman works for Asclepii
What is Daniel Katzman's role at the current company?
Daniel Katzman's current role is Biotech Executive and Entrepreneur.
What is Daniel Katzman's email address?
Daniel Katzman's email address is da****@****man.com
What is Daniel Katzman's direct phone number?
Daniel Katzman's direct phone number is +131473*****
What schools did Daniel Katzman attend?
Daniel Katzman attended Universidad Nacional De La Plata, Colegio Nacional De La Plata.
What skills is Daniel Katzman known for?
Daniel Katzman has skills like Start Ups, Medical Devices, Strategy, Business Strategy, Biotechnology, Business Development, Entrepreneurship, Strategic Planning, Product Launch, Life Sciences, Pharmaceutical Industry, Clinical Trials.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial